Navigation Links
Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal Transfusion
Date:8/29/2007

aggregation (and eventual amyloid plaque formation). These aggregates are associated with disease state progression in a number of brain-wasting and amyloid diseases.

Adlyfe, a privately-held corporation, was initially funded by the Defense Advanced Research Projects Agency (DARPA), the U.S. Army Medical Research and Materiel Command, the National Heart, Lung and Blood Institute, and Britain's Department for Environment, Food and Rural Affairs. More recently, Adlyfe raised additional funding with venture capital firms Canaan Venture Partners and Burrill Associates.

Internet Website: http://www.adlyfe.com

For More Information

Media:

Janine McCargo

1-646-536-7033

jmccargo@theruthgroup.com


'/>"/>
SOURCE Adlyfe
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...Holdings, Inc. today announced that it has been na...Technology Council (NJTC), a 1,200-member non-prof...tworking opportunities, information and advocacy f...earned the award based on criteria including marke... , , "We are delighted that the New Jersey ...
(Date:11/20/2008)... The following is being released by Center for Hea...AIDS Day Audio Media Conference , , WHEN:... EST , Call-in number: 1-800-949-8476 , RSVP...1xe41i2yre8rs , , WHY: With new HIV infe... treatment worldwide, advocates are calling on the...
(Date:11/20/2008)...GlaxoSmithKline (NYSE: ...and Drug Administration (FDA) granted accelerated ...atment of thrombocytopenia in patients with chroni...P) who have had an insufficient response to cortic...roval is a significant milestone for PROMACTA and ...
(Date:11/20/2008)...ire-FirstCall/ -- Arpida (SWX:,ARPN) announced to...ee of the,U.S. Food and Drug Administration (FDA)...enous iclaprim, an antibiotic currently in develop...ed skin and skin structure infections,(cSSSIs), i...phylococcus,aureus (MRSA). , Arpida remain...
Breaking Medicine Technology:Ikaria(R) Named Private Company of the Year by New Jersey Technology Council 2Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Direct Relief International Aims California Fire Response at Health Concerns 4445 1Direct Relief International Aims California Fire Response at Health Concerns 4445 2Illinois Planning Board Approves Central DuPage Hospital Bed Pavilion 4442 1Illinois Planning Board Approves Central DuPage Hospital Bed Pavilion 4442 2IdentiPHI Introduces Biometric Authentication Solution for Citrix Web Interface Environments 933 1IdentiPHI Introduces Biometric Authentication Solution for Citrix Web Interface Environments 933 2IdentiPHI Introduces Biometric Authentication Solution for Citrix Web Interface Environments 933 3Scripps Health Treats More Than 160 Fire Victims at Emergency Departments Across San Diego County 4440 1Scripps Health Treats More Than 160 Fire Victims at Emergency Departments Across San Diego County 4440 2
....Y.--(BUSINESS WIRE)--Jun 4, 2007 - Acorda,Therape... the,Company presented a "meta-analysis" or combin...R in multiple sclerosis during a,poster session at...,in MS (ACTRIMS) Meeting in Washington, D.C. on Sa...onsistent Improvement in Walking,Speed on the Time...
...SINESS WIRE)--Jun 4, 2007 - Cytogen Corporation,(N...trials,demonstrating that QUADRAMET (samarium Sm-1...d to prostate cancer patients who are also,receivi...-Aventis).,Clinical data also support further eval...t of prostate cancer in a Phase 2 program.,The res...
Other Medicine Technology:Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 2Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 4New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 2New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 3New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 4New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 5New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 6New Data for Cytogen's QUADRAMET Reported at Annual ASCO Meeting 7
(Date:11/21/2008)...vel technique to combat cancer, study says, , ...gian researchers have discovered that some cancer ...nd this might lead to new treatments that starve a...te, all cells in the body need to produce energy. ... that requires oxygen. Compared with normal cells,...
(Date:11/21/2008)... -- NursingCenter.com, the premier site,for onlin...ontent, has been,updated to improve the interacti...owered by Lippincott Williams & Wilkins (LWW),...iewed continuing education activities and free,ac...nursing journals.,Lippincott Williams & Wilki...
(Date:11/21/2008)...The general membership of the Medical,Advertising...s at their Annual,Awards Dinner to be held Februa...fetime Achievement Award will also be given. , ...g Hall of Fame are: , Ronald Pantello, who bega...,at Sudler & Hennessey. In 1980 he left Sudler...
(Date:11/21/2008)... cause genetic damage that can lead to disease , ... popular medications for treating attention-defici...ic damage linked to an increased risk for developi...by researchers at Duke University Medical Center a...revious one that reported biomarkers associated wi...
Breaking Medicine News(10 mins):Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 2Health News:Ronald Pantello, Harry Sweeney, and David Wood Voted Into Medical Advertising Hall of Fame. 3Health News:ADHD Medications Don't Pose Cancer Risk 2
...otland figures have revealed that about 34% of the...ese or overweight. The Information Statistics Divi...y the Government. Childhood obesity is directly co..., depression, osteoarthritis, back pain, low self-...
...n increase in demand for Palliative care for treat...rom Annual Survey of Hospitals, which has been rep...liative care is given to patients where chemothera...y a symptomatic treatment given to patients to les...
...ospital will soon be launched in Jharkhand for poo...e hospitals will begin operating from January next...hese mobile hospitals with expert doctors will cov...n 22 districts where the poor are deprived of medi...
...and Rawalpindi in Pakistan are on high alert follo...go Haemorrhagic Fever (CCHF).// While a woman died...tal (RGH) Sunday evening, another suspected case w... Institute of Medical Sciences (PIMS) here. Health...
Other Medicine News:Health News:Pakistan On Alert After Cases Of Fatal Fever 2